Article

Cd73-LNPs promotes antitumor T-cell immunity via amplifying Tlr3-mediated immunostimulatory dendritic cell activation

2026-02-02

Abstract excerpt

<title>Abstract</title> <p> <bold>Background:</bold> mRNA vaccines have emerged as highly promising therapeutic agents in the field of cancer immunotherapy. Nevertheless, the current limited immunogenicity of target antigens, along with a lack of systemic immune response, poses significant challenges to the effective implementation of mRNA vaccines. This study sought to evaluate the immunogenicity of the Cd73 p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c1be5155-13e9-5142-939e-7792d68c9e11
DOI: 10.21203/rs.3.rs-8715323/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cd73-LNPs promotes antitumor T-cell immunity via amplifying Tlr3-mediated immunostimulatory dendritic cell activationDOI 10.21203/rs.3.rs-8715323/v1Read

Second generation of LNP based mRNA vaccine leads to a T cell–inflamed tumor microenvironment favorable for improving PD-1/PD-L1 blocking therapy and long-term immunity in a cold tumor modelSemantic proximity Read

mRNA vaccine development and applications: A special focus on tumors (Review)Semantic proximity Read

mRNA vaccines in tumor targeted therapy: mechanism, clinical application, and development trendsSemantic proximity Read

mRNA vaccines as cancer therapiesSemantic proximity Read

Polymer-lipid hybrid nanoparticle enhances mRNA delivery and T cell-mediated immunitySemantic proximity Read

mRNA cancer vaccines: Advances, trends and challengesSemantic proximity Read

An anti-cancer cell therapy platform utilizing ex vivo physiologic dendritic cells expressing mRNA-encoded antigens and immune checkpoint blockersSemantic proximity Read

mRNA vaccines: a new era in vaccine developmentSemantic proximity Read

Spleen-targeted NeoPol-mL242 mRNA vaccine induces robust T-cell responses in a hepatocellular carcinoma modelSemantic proximity Read

Biomarkers of mRNA vaccine efficacy derived from mechanistic modeling of tumor-immune interactionsSemantic proximity Read

mRNA in cancer immunotherapy: beyond a source of antigenSemantic proximity Read

From structural design to delivery: mRNA therapeutics for cancer immunotherapySemantic proximity Read